News from the Genetic Toxicology Laboratory

The PACKSAFE project, whose theme is "Strategy for an integrated chemical safety of packaging materials in contact with food", funded by the National Research Agency (ANR) and on which the toxicology laboratory collaborates, was very recently the subject of an article...

At the annual congress of the French Society of Toxicology, held in Avignon on 24 and 25 November 2022, the work of the toxicology laboratory was rewarded with two "best poster" awards. The first poster focuses on the results of the FREEDOM Project (In vitro effects...

Creation of the NaMAsTE Research Group: Manufactured nanomaterials, toxicology, ecotoxicology and risks, towards controlled development (Nanomatériaux MAnufacturés, Toxicologie, Écotoxicologie et risques) On 6 December, the first working meeting was held of the...

The laboratory offers in vitro tests for the identification of endocrine disruptors. These are tests to reveal interactions with hormone receptors (oestrogens and androgens) or with steroidogenesis: the H295R steroidogenesis test, the E-Screen test, the MDA-kb2 test...

The ICH M7 guideline, for the evaluation and monitoring of mutagenic impurities contained in pharmaceutical products and the limitation of their potential carcinogenic risk, recommends the use of experimental data demonstrating structure-activity relationships...

Our portfolio is expanding with new tests and services: The DDR Kit or 'Multi Flow DNA Damage Repair Kit' (Litron Laboratories, USA) allows flow cytometric evaluation of the clastogenic, aneugenic and cytotoxic potential of substances in a screening context. Exposure...